APO Research
Talk to an analyst

APO RESEARCH · REPORT

Allergic Conjunctivitis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Allergic Conjunctivitis Drug Industry Research Report 2026

22 December 2025128 pages

Choose your research edition.

Industry ResearchAllergic Conjunctivitis Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Allergic Conjunctivitis Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Allergic Conjunctivitis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allergic Conjunctivitis Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Allergic Conjunctivitis Drug Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Allergic Conjunctivitis Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Allergic Conjunctivitis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Allergic Conjunctivitis Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Allergic Conjunctivitis Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Allergic Conjunctivitis Drug include Accolade Pharmaceuticals LLC, Aldeyra Therapeutics Inc, AlleCures Inc, Allergan Plc, Clevexel Pharma SAS, Griffin Discoveries BV, Ocular Therapeutix Inc, Ohr Pharmaceutical Inc and Portola Pharmaceuticals Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Allergic Conjunctivitis Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Allergic Conjunctivitis Drug Market by Company

Accolade Pharmaceuticals LLC

Aldeyra Therapeutics Inc

AlleCures Inc

Allergan Plc

Clevexel Pharma SAS

Griffin Discoveries BV

Ocular Therapeutix Inc

Ohr Pharmaceutical Inc

Portola Pharmaceuticals Inc

Realm Therapeutics Plc

Re-Pharm Ltd

Sylentis SAU

Xencor Inc

Allergic Conjunctivitis Drug Segment by Type

Dexamethasone Acetate SR

CVXL-0074

CPC-888

AGN-229666

ADX-102

Others

Allergic Conjunctivitis Drug Segment by Application

Clinic

Hospital

Research Center

Others

Allergic Conjunctivitis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergic Conjunctivitis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allergic Conjunctivitis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergic Conjunctivitis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Allergic Conjunctivitis Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Allergic Conjunctivitis Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Allergic Conjunctivitis Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Allergic Conjunctivitis Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Allergic Conjunctivitis Drug Sales (k units) of Manufacturers (2021-2026) Table 7. Global Allergic Conjunctivitis Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Allergic Conjunctivitis Drug Revenue of Manufacturers (2021-2026) Table 9. Global Allergic Conjunctivitis Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Allergic Conjunctivitis Drug Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Allergic Conjunctivitis Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Allergic Conjunctivitis Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Allergic Conjunctivitis Drug, Product Type & Application Table 14. Global Allergic Conjunctivitis Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Allergic Conjunctivitis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Accolade Pharmaceuticals LLC Company Information Table 19. Accolade Pharmaceuticals LLC Business Overview Table 20. Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Product Portfolio Table 22. Accolade Pharmaceuticals LLC Recent Developments Table 23. Aldeyra Therapeutics Inc Company Information Table 24. Aldeyra Therapeutics Inc Business Overview Table 25. Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Product Portfolio Table 27. Aldeyra Therapeutics Inc Recent Developments Table 28. AlleCures Inc Company Information Table 29. AlleCures Inc Business Overview Table 30. AlleCures Inc Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. AlleCures Inc Allergic Conjunctivitis Drug Product Portfolio Table 32. AlleCures Inc Recent Developments Table 33. Allergan Plc Company Information Table 34. Allergan Plc Business Overview Table 35. Allergan Plc Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Allergan Plc Allergic Conjunctivitis Drug Product Portfolio Table 37. Allergan Plc Recent Developments Table 38. Clevexel Pharma SAS Company Information Table 39. Clevexel Pharma SAS Business Overview Table 40. Clevexel Pharma SAS Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Clevexel Pharma SAS Allergic Conjunctivitis Drug Product Portfolio Table 42. Clevexel Pharma SAS Recent Developments Table 43. Griffin Discoveries BV Company Information Table 44. Griffin Discoveries BV Business Overview Table 45. Griffin Discoveries BV Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Griffin Discoveries BV Allergic Conjunctivitis Drug Product Portfolio Table 47. Griffin Discoveries BV Recent Developments Table 48. Ocular Therapeutix Inc Company Information Table 49. Ocular Therapeutix Inc Business Overview Table 50. Ocular Therapeutix Inc Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Ocular Therapeutix Inc Allergic Conjunctivitis Drug Product Portfolio Table 52. Ocular Therapeutix Inc Recent Developments Table 53. Ohr Pharmaceutical Inc Company Information Table 54. Ohr Pharmaceutical Inc Business Overview Table 55. Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Product Portfolio Table 57. Ohr Pharmaceutical Inc Recent Developments Table 58. Portola Pharmaceuticals Inc Company Information Table 59. Portola Pharmaceuticals Inc Business Overview Table 60. Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Product Portfolio Table 62. Portola Pharmaceuticals Inc Recent Developments Table 63. Realm Therapeutics Plc Company Information Table 64. Realm Therapeutics Plc Business Overview Table 65. Realm Therapeutics Plc Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Realm Therapeutics Plc Allergic Conjunctivitis Drug Product Portfolio Table 67. Realm Therapeutics Plc Recent Developments Table 68. Re-Pharm Ltd Company Information Table 69. Re-Pharm Ltd Business Overview Table 70. Re-Pharm Ltd Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Re-Pharm Ltd Allergic Conjunctivitis Drug Product Portfolio Table 72. Re-Pharm Ltd Recent Developments Table 73. Sylentis SAU Company Information Table 74. Sylentis SAU Business Overview Table 75. Sylentis SAU Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sylentis SAU Allergic Conjunctivitis Drug Product Portfolio Table 77. Sylentis SAU Recent Developments Table 78. Xencor Inc Company Information Table 79. Xencor Inc Business Overview Table 80. Xencor Inc Allergic Conjunctivitis Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Xencor Inc Allergic Conjunctivitis Drug Product Portfolio Table 82. Xencor Inc Recent Developments Table 83. Global Allergic Conjunctivitis Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Allergic Conjunctivitis Drug Sales by Region (2021-2026) & (k units) Table 85. Global Allergic Conjunctivitis Drug Sales Market Share by Region (2021-2026) Table 86. Global Allergic Conjunctivitis Drug Sales by Region (2027-2032) & (k units) Table 87. Global Allergic Conjunctivitis Drug Sales Market Share by Region (2027-2032) Table 88. Global Allergic Conjunctivitis Drug Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Allergic Conjunctivitis Drug Revenue Market Share by Region (2021-2026) Table 90. Global Allergic Conjunctivitis Drug Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Allergic Conjunctivitis Drug Revenue Market Share by Region (2027-2032) Table 92. North America Allergic Conjunctivitis Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Allergic Conjunctivitis Drug Sales by Country (2021-2026) & (k units) Table 94. North America Allergic Conjunctivitis Drug Sales by Country (2027-2032) & (k units) Table 95. North America Allergic Conjunctivitis Drug Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Allergic Conjunctivitis Drug Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Allergic Conjunctivitis Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Allergic Conjunctivitis Drug Sales by Country (2021-2026) & (k units) Table 99. Europe Allergic Conjunctivitis Drug Sales by Country (2027-2032) & (k units) Table 100. Europe Allergic Conjunctivitis Drug Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Allergic Conjunctivitis Drug Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Allergic Conjunctivitis Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Allergic Conjunctivitis Drug Sales by Country (2021-2026) & (k units) Table 104. Asia Pacific Allergic Conjunctivitis Drug Sales by Country (2027-2032) & (k units) Table 105. Asia Pacific Allergic Conjunctivitis Drug Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Allergic Conjunctivitis Drug Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Allergic Conjunctivitis Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Allergic Conjunctivitis Drug Sales by Country (2021-2026) & (k units) Table 109. South America Allergic Conjunctivitis Drug Sales by Country (2027-2032) & (k units) Table 110. South America Allergic Conjunctivitis Drug Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Allergic Conjunctivitis Drug Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Allergic Conjunctivitis Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Allergic Conjunctivitis Drug Sales by Country (2021-2026) & (k units) Table 114. Middle East and Africa Allergic Conjunctivitis Drug Sales by Country (2027-2032) & (k units) Table 115. Middle East and Africa Allergic Conjunctivitis Drug Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Allergic Conjunctivitis Drug Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Allergic Conjunctivitis Drug Sales by Type (2021-2026) & (k units) Table 118. Global Allergic Conjunctivitis Drug Sales by Type (2027-2032) & (k units) Table 119. Global Allergic Conjunctivitis Drug Sales Market Share by Type (2021-2026) Table 120. Global Allergic Conjunctivitis Drug Sales Market Share by Type (2027-2032) Table 121. Global Allergic Conjunctivitis Drug Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Allergic Conjunctivitis Drug Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Allergic Conjunctivitis Drug Revenue Market Share by Type (2021-2026) Table 124. Global Allergic Conjunctivitis Drug Revenue Market Share by Type (2027-2032) Table 125. Global Allergic Conjunctivitis Drug Price by Type (2021-2026) & (US$/unit) Table 126. Global Allergic Conjunctivitis Drug Price by Type (2027-2032) & (US$/unit) Table 127. Global Allergic Conjunctivitis Drug Sales by Application (2021-2026) & (k units) Table 128. Global Allergic Conjunctivitis Drug Sales by Application (2027-2032) & (k units) Table 129. Global Allergic Conjunctivitis Drug Sales Market Share by Application (2021-2026) Table 130. Global Allergic Conjunctivitis Drug Sales Market Share by Application (2027-2032) Table 131. Global Allergic Conjunctivitis Drug Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Allergic Conjunctivitis Drug Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Allergic Conjunctivitis Drug Revenue Market Share by Application (2021-2026) Table 134. Global Allergic Conjunctivitis Drug Revenue Market Share by Application (2027-2032) Table 135. Global Allergic Conjunctivitis Drug Price by Application (2021-2026) & (US$/unit) Table 136. Global Allergic Conjunctivitis Drug Price by Application (2027-2032) & (US$/unit) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Allergic Conjunctivitis Drug Distributors List Table 140. Allergic Conjunctivitis Drug Customers List Table 141. Allergic Conjunctivitis Drug Industry Trends Table 142. Allergic Conjunctivitis Drug Industry Drivers Table 143. Allergic Conjunctivitis Drug Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Allergic Conjunctivitis Drug Product Image Figure 5. Global Allergic Conjunctivitis Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Allergic Conjunctivitis Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Allergic Conjunctivitis Drug Sales (2021-2032) & (k units) Figure 8. Global Allergic Conjunctivitis Drug Average Price (US$/unit) & (2021-2032) Figure 9. Dexamethasone Acetate SR Product Image Figure 10. CVXL-0074 Product Image Figure 11. CPC-888 Product Image Figure 12. AGN-229666 Product Image Figure 13. ADX-102 Product Image Figure 14. Others Product Image Figure 15. Clinic Product Image Figure 16. Hospital Product Image Figure 17. Research Center Product Image Figure 18. Others Product Image Figure 19. Global Allergic Conjunctivitis Drug Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Allergic Conjunctivitis Drug, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Allergic Conjunctivitis Drug Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Allergic Conjunctivitis Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Allergic Conjunctivitis Drug Sales by Region in 2025 Figure 25. Global Allergic Conjunctivitis Drug Revenue by Region in 2025 Figure 26. North America Allergic Conjunctivitis Drug Market Size by Country in 2025 Figure 27. North America Allergic Conjunctivitis Drug Sales Market Share by Country (2021-2032) Figure 28. North America Allergic Conjunctivitis Drug Revenue Market Share by Country (2021-2032) Figure 29. United States Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Allergic Conjunctivitis Drug Market Size by Country in 2025 Figure 33. Europe Allergic Conjunctivitis Drug Sales Market Share by Country (2021-2032) Figure 34. Europe Allergic Conjunctivitis Drug Revenue Market Share by Country (2021-2032) Figure 35. Germany Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Allergic Conjunctivitis Drug Market Size by Country in 2025 Figure 46. Asia Pacific Allergic Conjunctivitis Drug Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Allergic Conjunctivitis Drug Revenue Market Share by Country (2021-2032) Figure 48. China Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Allergic Conjunctivitis Drug Market Size by Country in 2025 Figure 57. South America Allergic Conjunctivitis Drug Sales Market Share by Country (2021-2032) Figure 58. South America Allergic Conjunctivitis Drug Revenue Market Share by Country (2021-2032) Figure 59. Brazil Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Middle East and Africa Allergic Conjunctivitis Drug Market Size by Country in 2025 Figure 63. Middle East and Africa Allergic Conjunctivitis Drug Sales Market Share by Country (2021-2032) Figure 64. Middle East and Africa Allergic Conjunctivitis Drug Revenue Market Share by Country (2021-2032) Figure 65. Egypt Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. South Africa Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Israel Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Türkiye Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. GCC Countries Allergic Conjunctivitis Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Global Allergic Conjunctivitis Drug Sales Market Share by Type (2021-2032) Figure 71. Global Allergic Conjunctivitis Drug Revenue Market Share by Type (2021-2032) Figure 72. Global Allergic Conjunctivitis Drug Price (US$/unit) by Type (2021-2032) Figure 73. Global Allergic Conjunctivitis Drug Sales Market Share by Application (2021-2032) Figure 74. Global Allergic Conjunctivitis Drug Revenue Market Share by Application (2021-2032) Figure 75. Global Allergic Conjunctivitis Drug Price (US$/unit) by Application (2021-2032) Figure 76. Allergic Conjunctivitis Drug Value Chain Figure 77. Allergic Conjunctivitis Drug Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Allergic Conjunctivitis Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Dexamethasone Acetate SR
  • CVXL-0074
  • CPC-888
  • AGN-229666
  • ADX-102
  • Others
Applications
  • Clinic
  • Hospital
  • Research Center
  • Others
Companies covered
  • Accolade Pharmaceuticals LLC
  • Aldeyra Therapeutics Inc
  • AlleCures Inc
  • Allergan Plc
  • Clevexel Pharma SAS
  • Griffin Discoveries BV
  • Ocular Therapeutix Inc
  • Ohr Pharmaceutical Inc
  • Portola Pharmaceuticals Inc
  • Realm Therapeutics Plc
  • Re-Pharm Ltd
  • Sylentis SAU
  • Xencor Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Allergic Conjunctivitis Drug Market Size (2021-2032)
  4. 2.2.2 Global Allergic Conjunctivitis Drug Sales (2021-2032)
  5. 2.2.3 Global Allergic Conjunctivitis Drug Market Average Price (2021-2032)
  6. 2.3 Allergic Conjunctivitis Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Dexamethasone Acetate SR
  9. 2.3.3 CVXL-0074
  10. 2.3.4 CPC-888
  11. 2.3.5 AGN-229666
  12. 2.3.6 ADX-102
  13. 2.3.7 Others
  14. 2.4 Allergic Conjunctivitis Drug by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Clinic
  17. 2.4.3 Hospital
  18. 2.4.4 Research Center
  19. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Allergic Conjunctivitis Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Allergic Conjunctivitis Drug Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Allergic Conjunctivitis Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Allergic Conjunctivitis Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Allergic Conjunctivitis Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Allergic Conjunctivitis Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Allergic Conjunctivitis Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Allergic Conjunctivitis Drug, Established Date
  9. 3.9 Global Allergic Conjunctivitis Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Accolade Pharmaceuticals LLC
  2. 4.1.1 Accolade Pharmaceuticals LLC Company Information
  3. 4.1.2 Accolade Pharmaceuticals LLC Business Overview
  4. 4.1.3 Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Product Portfolio
  6. 4.1.5 Accolade Pharmaceuticals LLC Recent Developments
  7. 4.2 Aldeyra Therapeutics Inc
  8. 4.2.1 Aldeyra Therapeutics Inc Company Information
  9. 4.2.2 Aldeyra Therapeutics Inc Business Overview
  10. 4.2.3 Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Product Portfolio
  12. 4.2.5 Aldeyra Therapeutics Inc Recent Developments
  13. 4.3 AlleCures Inc
  14. 4.3.1 AlleCures Inc Company Information
  15. 4.3.2 AlleCures Inc Business Overview
  16. 4.3.3 AlleCures Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 AlleCures Inc Allergic Conjunctivitis Drug Product Portfolio
  18. 4.3.5 AlleCures Inc Recent Developments
  19. 4.4 Allergan Plc
  20. 4.4.1 Allergan Plc Company Information
  21. 4.4.2 Allergan Plc Business Overview
  22. 4.4.3 Allergan Plc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Allergan Plc Allergic Conjunctivitis Drug Product Portfolio
  24. 4.4.5 Allergan Plc Recent Developments
  25. 4.5 Clevexel Pharma SAS
  26. 4.5.1 Clevexel Pharma SAS Company Information
  27. 4.5.2 Clevexel Pharma SAS Business Overview
  28. 4.5.3 Clevexel Pharma SAS Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Clevexel Pharma SAS Allergic Conjunctivitis Drug Product Portfolio
  30. 4.5.5 Clevexel Pharma SAS Recent Developments
  31. 4.6 Griffin Discoveries BV
  32. 4.6.1 Griffin Discoveries BV Company Information
  33. 4.6.2 Griffin Discoveries BV Business Overview
  34. 4.6.3 Griffin Discoveries BV Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Griffin Discoveries BV Allergic Conjunctivitis Drug Product Portfolio
  36. 4.6.5 Griffin Discoveries BV Recent Developments
  37. 4.7 Ocular Therapeutix Inc
  38. 4.7.1 Ocular Therapeutix Inc Company Information
  39. 4.7.2 Ocular Therapeutix Inc Business Overview
  40. 4.7.3 Ocular Therapeutix Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Ocular Therapeutix Inc Allergic Conjunctivitis Drug Product Portfolio
  42. 4.7.5 Ocular Therapeutix Inc Recent Developments
  43. 4.8 Ohr Pharmaceutical Inc
  44. 4.8.1 Ohr Pharmaceutical Inc Company Information
  45. 4.8.2 Ohr Pharmaceutical Inc Business Overview
  46. 4.8.3 Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Product Portfolio
  48. 4.8.5 Ohr Pharmaceutical Inc Recent Developments
  49. 4.9 Portola Pharmaceuticals Inc
  50. 4.9.1 Portola Pharmaceuticals Inc Company Information
  51. 4.9.2 Portola Pharmaceuticals Inc Business Overview
  52. 4.9.3 Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Product Portfolio
  54. 4.9.5 Portola Pharmaceuticals Inc Recent Developments
  55. 4.10 Realm Therapeutics Plc
  56. 4.10.1 Realm Therapeutics Plc Company Information
  57. 4.10.2 Realm Therapeutics Plc Business Overview
  58. 4.10.3 Realm Therapeutics Plc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Realm Therapeutics Plc Allergic Conjunctivitis Drug Product Portfolio
  60. 4.10.5 Realm Therapeutics Plc Recent Developments
  61. 4.11 Re-Pharm Ltd
  62. 4.11.1 Re-Pharm Ltd Company Information
  63. 4.11.2 Re-Pharm Ltd Business Overview
  64. 4.11.3 Re-Pharm Ltd Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Re-Pharm Ltd Allergic Conjunctivitis Drug Product Portfolio
  66. 4.11.5 Re-Pharm Ltd Recent Developments
  67. 4.12 Sylentis SAU
  68. 4.12.1 Sylentis SAU Company Information
  69. 4.12.2 Sylentis SAU Business Overview
  70. 4.12.3 Sylentis SAU Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Sylentis SAU Allergic Conjunctivitis Drug Product Portfolio
  72. 4.12.5 Sylentis SAU Recent Developments
  73. 4.13 Xencor Inc
  74. 4.13.1 Xencor Inc Company Information
  75. 4.13.2 Xencor Inc Business Overview
  76. 4.13.3 Xencor Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Xencor Inc Allergic Conjunctivitis Drug Product Portfolio
  78. 4.13.5 Xencor Inc Recent Developments
5 Global Allergic Conjunctivitis Drug Market Scenario by Region
  1. 5.1 Global Allergic Conjunctivitis Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Allergic Conjunctivitis Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Allergic Conjunctivitis Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Allergic Conjunctivitis Drug Sales by Region: 2027-2032
  5. 5.3 Global Allergic Conjunctivitis Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Allergic Conjunctivitis Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Allergic Conjunctivitis Drug Revenue by Region: 2027-2032
  8. 5.4 North America Allergic Conjunctivitis Drug Market Facts & Figures by Country
  9. 5.4.1 North America Allergic Conjunctivitis Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Allergic Conjunctivitis Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Allergic Conjunctivitis Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Allergic Conjunctivitis Drug Market Facts & Figures by Country
  16. 5.5.1 Europe Allergic Conjunctivitis Drug Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Allergic Conjunctivitis Drug Sales by Country (2021-2032)
  18. 5.5.3 Europe Allergic Conjunctivitis Drug Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Allergic Conjunctivitis Drug Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Allergic Conjunctivitis Drug Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Allergic Conjunctivitis Drug Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Allergic Conjunctivitis Drug Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Allergic Conjunctivitis Drug Market Facts & Figures by Country
  41. 5.7.1 South America Allergic Conjunctivitis Drug Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Allergic Conjunctivitis Drug Sales by Country (2021-2032)
  43. 5.7.3 South America Allergic Conjunctivitis Drug Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Allergic Conjunctivitis Drug Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Allergic Conjunctivitis Drug Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Allergic Conjunctivitis Drug Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Allergic Conjunctivitis Drug Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Allergic Conjunctivitis Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Allergic Conjunctivitis Drug Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Allergic Conjunctivitis Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Allergic Conjunctivitis Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Allergic Conjunctivitis Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Allergic Conjunctivitis Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Allergic Conjunctivitis Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Allergic Conjunctivitis Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Allergic Conjunctivitis Drug Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Allergic Conjunctivitis Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Allergic Conjunctivitis Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Allergic Conjunctivitis Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Allergic Conjunctivitis Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Allergic Conjunctivitis Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Allergic Conjunctivitis Drug Value Chain Analysis
  2. 8.1.1 Allergic Conjunctivitis Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Allergic Conjunctivitis Drug Production Mode & Process
  5. 8.2 Allergic Conjunctivitis Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Allergic Conjunctivitis Drug Distributors
  8. 8.2.3 Allergic Conjunctivitis Drug Customers
9 Global Allergic Conjunctivitis Drug Analyzing Market Dynamics
  1. 9.1 Allergic Conjunctivitis Drug Industry Trends
  2. 9.2 Allergic Conjunctivitis Drug Industry Drivers
  3. 9.3 Allergic Conjunctivitis Drug Industry Opportunities and Challenges
  4. 9.4 Allergic Conjunctivitis Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst